The aim of our study was to determine if the amniotic fluid alpha-fetoprote
in (AFP) level could be a useful predictive biochemical marker of pregnancy
outcome. Amniotic fluid AFP measurement was prospectively carried out over
a three-year period. After excluding factors susceptible to modifying AFP
measurements, 587 subjects with gestational age between 14 and 20 weeks wer
e selected to compare the amniotic fluid AFP mean levels depending on the o
ccurrence of an adverse outcome. No significant associations between amniot
ic fluid AFP level and poor pregnancy outcome, i.e. pre-eclampsia, preterm
delivery, premature rupture of fetal membranes, fetal growth retardation an
d placental abnormalities were observed. The routine measurement of amnioti
c fluid alpha-fetoprotein during an amniocentesis procedure was not conside
red useful in predicting pregnancy complications. (C) 1999 John Wiley & Son
s, Ltd.